Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1854 of 6351
-
New drug may offer longer-lasting bleed control for rare platelet disorder
Disease control CompletedGlanzmann thrombasthenia is a rare genetic disorder caused by the absence or the dysfunction of the main receptor present on the surface of platelets, integrin αIIbβ3 or GPIIb-IIIa. The lack of this protein on the surface of platelets no longer allows these blood cells to bind t…
Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Lung cancer patients get new hope with Arginine-Starving drug combo
Disease control Stopped earlyIn this study, patients with small cell or non-small cell lung cancer will receive ADI-PEG 20, gemcitabine, and docetaxel after demonstrated progression on frontline therapy. In phase I of the study, up to 6 dose levels will be tested to find the recommended phase II dose (RP2D),…
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New hope for kids with severe psoriasis: QLETLI shows promise
Disease control CompletedThis study is a multicenter, prospective, observational phase IV clinical study. A total of 80 children and adolescents with severe plaque psoriasis were included in the study. The study is expected to last for 24 weeks (169 days). This study will evaluate the efficacy and safety…
Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Shorter radiation before breast cancer surgery may be just as safe
Disease control Recruiting nowTo compare the outcomes of and responses to 2 different radiation therapy schedules (the standard radiation amount and number of doses versus less radiation and fewer doses) that are being given before having breast cancer surgery (cancer removal and reconstruction).
Phase 3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New cocktail targets tough lymphomas
Disease control CompletedBackground: Non-Hodgkin lymphomas are blood cancers that can be difficult to treat. They can also return after treatment. Examples include diffuse large B-cell lymphoma (DLBCL) and peripheral T-cell lymphoma (PTCL). More effective treatments are needed for these diseases. Objec…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New DNA HIV vaccine shows promise in early safety trial
Vaccine CompletedThis is a randomized open-label trial to examine the safety and immunogenicity of INO-6160 (synthetic DNAs encoding a native-like HIV Env Trimer and Interleukin-12), alone or in a prime-boost regimen with VRC HIV Env Trimer 4571 adjuvanted with 3M-052-AF + Alum. The primary hypot…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 26, 2026 13:13 UTC
-
New narcolepsy drug TAK-861 tested for Long-Term safety
Disease control Recruiting nowThe main aim is to evaluate the safety and tolerability of TAK-861 in participants with type 1 narcolepsy, who were exposed to previously tested doses of TAK-861.
Phase 2/3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New drug GEn-1124 tested for severe lung failure
Disease control Recruiting nowGEn1E-1124-002 is a two-part Phase 2 study to evaluate the safety and tolerability of GEn-1124 in subjects with ARDS. Treatment with IV infusion dosing as early as possible after ARDS diagnosis. Subjects will be given a second dose approximately 8 hours after the first dose and w…
Phase 2 • Sponsor: GEn1E Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New asthma drug tezspire put to the test in Long-Term safety study
Disease control OngoingThe purpose of the investigation is to confirm the followings under the post-marketing actual long-term use of Tezspire. 1. Development of related AEs 2. Contributing factors possibly having an impact on the safety and effectiveness 3. Development of unexpected related AEs
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a common diabetes drug and fasting shrink breast tumors before surgery?
Disease control OngoingThis phase IIb trial studies the combined effect of prolonged nightly fasting and metformin hydrochloride extended release in decreasing breast tumor cell proliferation and other biomarkers of breast cancer. Preventing invasive breast cancer or DCIS. Metformin is widely used to t…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a VR avatar help people stay off opioids?
Symptom relief CompletedThe goal of this clinical trial is to demonstrate the commercial potential for a novel virtual reality (VR) intervention in preparation for Phase II development. This clinical trial will test the VR intervention for efficacy in reducing opioid use, increasing abstinence, and othe…
Sponsor: Indiana University • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Heart scan study sees if new drug clears sticky proteins
Disease control OngoingThe purpose of this study is to examine the changes in amyloid myocardial burden in a subset of the population participating in the ION682884-CS2 (NCT04136171) study, up to 150 participants, after treatment with eplontersen or placebo based on scintigraphy scans performed at Week…
Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
AI heart reader aims to spot deadly rhythms before It's too late
Diagnosis Recruiting nowWILLEM is a multi-center, prospective and retrospective cohort study. The study will assess the performance of a cloud-based and AI-powered ECG analysis platform, named Willem™, developed to detect arrhythmias and other abnormal cardiac patterns. The main questions it aims to an…
Sponsor: Idoven 1903 S.L. • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
Can elastic bands help volleyball players jump higher?
Symptom relief CompletedThe aim of the study was to compare the effects of three 10-week training interventions on vertical jump performance in volleyball players. Jump performance was assessed using the countermovement jump with arm swing (CMJ+AS) and drop jumps from heights of 20 cm (DJ20) and 60 cm (…
Sponsor: Gdansk University of Physical Education and Sport • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Can a team approach to rehab ease chronic back pain?
Symptom relief CompletedThe overall aim of this pilot RCT is to assess the feasibility of conducting a future definitive randomized control trial (RCT) for evaluating the effectiveness of an interprofessional rehabilitation program compared to the usual care in adults with chronic low back pain in Ethio…
Sponsor: Sintayehu Wami • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Experimental triple therapy takes on Hard-to-Treat Head-Neck cancer
Disease control Recruiting nowThis is a prospective, open-label, single arm, non-randomized study of RiMO-301 with hypofractionated radiation and a PD-1 Inhibitor in patients with unresectable, recurrent or metastatic head-neck cancer.
Phase 1/2 • Sponsor: Coordination Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:45 UTC
-
Robot or human? new study compares arm therapy methods for stroke patients
Symptom relief CompletedThis study aims to compare the outcomes of upper limb motor therapy conducted by a physiotherapist with robot-assisted therapy using the Luna EMG device in patients in the subacute phase after stroke. Additionally, the study will examine the correlation between changes in muscle …
Sponsor: Wroclaw University of Health and Sport Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New eczema drug shows promise in Long-Term trial
Disease control OngoingThis is a single group, 1-arm, long-term safety study for treatment of participants with moderate to severe atopic dermatitis (AD). The purpose of this study is to characterize the long-term safety and efficacy of amlitelimab in treated participants with age ≥12 years old with m…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New psoriasis pill shows promise in early trial
Disease control CompletedThe purpose of this study is to evaluate clinical effectiveness and safety of BMS-986322 in participants with moderate-to-severe psoriasis.
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Text messages may boost mental health care for new and expecting mothers
Symptom relief OngoingThe purpose of the study is to compare a text message-based mental health and substance use screening and referral to a treatment program, called Listening to Women and Pregnant and Postpartum People (LTWP), to standard of care in-person mental health and substance use screening …
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC